Sharemaestro Newsreel

BioLife Solutions Inc (BLFS) Stock News Today

Align Technology Expanding its Global Operations

Align Technology announced plans to open its first manufacturing facility in Hyderabad, India, by next year. This expansion, involving a $200 million investment and creating over 300 jobs, aims to bring operations closer to high-growth markets like India and enhance supply chain resilience. The …

Femasys Inc (FEMY) Stock News Today

ResMed (RMD) investor Michael Farrell plans 4,991-share stock sale after option exercise

ResMed (RMD) investor Michael Farrell has filed a Form 144 indicating a proposed sale of 4,991 shares of common stock on August 7, 2026, following a stock option exercise. The shares are intended to be sold for cash via Fidelity Brokerage Services LLC on …

Earnings call transcript: Embecta beats Q3 2026 estimates, shares jump premarket

Femasys Stock Falls 11% Over Announcement Of $30 Mln Private Placement

Femasys Inc. (FEMY) shares dropped 11.07% on Friday following the announcement of a $30 million private placement with accredited investors, including Nantahala Capital, Rosalind Advisors, and company management. The agreement involves the sale of 9.37 million shares of common stock and pre-funded warrants, plus …

Femasys prices USD 30 million private placement at USD 3.2 per share

Femasys has priced a $30 million private placement of common stock, pre-funded warrants, and accompanying warrants with accredited investors at $3.20 per share. The deal includes 9,374,999 common shares and pre-funded warrants, each paired with two 3-year warrants covering 18,749,998 shares, with an exercise …

Femasys Could Receive Up to $60M If Warrants Are Exercised

Femasys (NASDAQ: FEMY) has entered into a $30 million private placement agreement with accredited investors, led by Nantahala Capital. The deal involves selling common shares and pre-funded warrants, bundled with accompanying warrants, which if fully exercised for cash, could provide Femasys with an additional …

Director At AtriCure Sells $134K Of Stock

AtriCure Director Maggie Yuen sold 3,500 shares of the company's stock for a total of $134,470, as reported in an SEC filing on August 7. The company's shares were trading up 2.89% at $39.49 following the report. AtriCure demonstrated strong revenue growth of 12.83% …

Icu Medical stock hits 52-week high at 182.35 USD

ICU Medical (ICUI) stock reached a new 52-week high of $182.35, driven by positive market sentiment and strong financial performance. The company exceeded Q2 earnings and revenue expectations and raised its full-year EPS guidance, further boosted by an analyst upgrade to a $200 price …

The Cooper Companies, Inc. (NASDAQ:COO) Receives Consensus Recommendation of "Hold" from Analysts

The Cooper Companies, Inc. (NASDAQ:COO) has received a consensus "Hold" recommendation from seventeen analysts, with an average 12-month price target of $81.36. The company recently reported strong quarterly results, exceeding EPS and revenue estimates, and provided positive fiscal 2026 EPS guidance. Despite mixed recent …

Warby Parker (WRBY) Could Be 10% Undervalued Following Profit Return And Guidance Reaffirmation

Form 8K STAAR Surgical Company For: 6 August By Investing.com

This article announces the filing of a Form 8K by STAAR Surgical Company on August 6th. The brief piece from Investing.com indicates that the Form 8K is publicly available for review. The publication also provides various market data and other news headlines.

Stocks in play: Bausch + Lomb Corporation

Bausch + Lomb Corporation announced changes to its Board of Directors, leading to a slight drop in its share price. The shares of T.BLCO are currently trading down $0.20 at $16.54. This brief update highlights recent company news affecting its stock performance.

AtriCure director Maggie Yuen sells $134,470 in stock

AtriCure Director Maggie Yuen sold 3,500 shares of the company's common stock for $134,470 on August 5, 2026. This transaction leaves Yuen with 14,015 shares. The sale occurred while AtriCure's stock is trading near its 52-week high, despite the company recently surpassing Q2 2026 …

AtriCure, Inc. (ATRC) director sells 3,564 shares at $38.80

AtriCure, Inc. director Karen Prange sold 3,564 shares of common stock at $38.80 per share on August 5, 2026, in an open market or private transaction. Following this sale, Prange directly holds 22,809 shares of AtriCure. The transaction was reported in a Form 4 …

Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings

Pro-Dex Inc (PDEX) Stock News Today

BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary

BioLife Solutions, Inc. has released its earnings summary for the quarter that ended on June 30. The full article provides detailed results of the company's financial performance during this period.

Femasys secures $30 million private placement financing By Investing.com

Femasys Inc. announced a $30 million private placement financing agreement with accredited investors, led by Nantahala Capital, with participation from other healthcare funds and Femasys management. The deal involves selling common stock and pre-funded warrants with accompanying warrants, potentially raising an additional $60 million …

Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Nephros Inc (NEPH), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that three analysts rate NEPH as a "Buy" with an average price target of $7.00. The forecast also includes expected …

RBC Capital Adjusts PT on ResMed to $244 From $234, Maintains Sector Perform Rating

RBC Capital has increased its price target for ResMed (RMD) to $244 from $234, while maintaining a Sector Perform rating on the stock. This adjustment comes shortly after ResMed reported its fiscal Q4 non-GAAP earnings and revenue were up, though shares initially fell.

Aptargroup Inc (ATR) Stock News Today

Femasys Inc (FEMY) Earnings Forecast: Future EPS & Revenue Growth Estimates

Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

The Trade Desk (NASDAQ: TTD) reported weaker-than-expected Q2 financial results, with earnings per share missing estimates by 15% and revenue falling short of Street estimates. This news caused Trade Desk shares to drop significantly in pre-market trading, impacting other stocks such as Sezzle, Quidelortho, …

FMR LLC discloses 5.5% Medline Inc (MDLN) Class A ownership stake

FMR LLC has disclosed a 5.5% ownership stake in Medline Inc.'s Class A common stock, totaling 46,929,203.69 shares as of June 30, 2026. Abigail P. Johnson, controlling FMR LLC, holds sole dispositive power over these shares. The filing indicates sole voting power over 45,718,763.34 …

ETFs Investing in BioLife Solutions, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of BioLife Solutions, Inc. (BLFS). The ETFs are primarily focused on small-cap companies and are managed by various financial institutions like BlackRock, State Street Corp., and The Vanguard Group. The provided table includes …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ: AZTA) on behalf of investors. This follows Azenta's Q2 2026 financial results, which missed consensus estimates for EPS and revenue, reported a $149 million goodwill impairment, and led to a reduced …

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts

AtriCure, Inc. (NASDAQ:ATRC) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $48.50. The company recently reported strong quarterly results, exceeding EPS and revenue estimates, and provided positive fiscal year 2026 guidance. While institutional ownership is high …

Resmed Reports Strong Q4 Results and Dividend Increase

Resmed (RMD) reported strong Q4 and full-year fiscal 2026 results, with revenue up 9% and 10% respectively, and a 17% increase in non-GAAP diluted EPS. The company generated significant free cash flow, returned $1.0 billion to shareholders, and raised its quarterly dividend by 10% …

embecta Reports Third Quarter Fiscal 2026 Financial Results

Embecta Corp. announced its third-quarter fiscal 2026 financial results on August 7, 2026, holding a conference call and live webcast for analysts and investors. The company is transitioning from focusing solely on insulin delivery to becoming a broader medical supplies company. While the official …

Embecta reports Q3 FY2026 revenue $271.7M, GAAP net income $21.1M; raises adjusted EPS guidance

Embecta (EMBC) reported its Q3 FY2026 financial results, achieving revenues of $271.7 million and a GAAP net income of $21.1 million. The company posted adjusted diluted EPS of $0.56 and has raised its full-year adjusted operating margin and adjusted EPS guidance, while reaffirming full-year …

BNGO Q2'26 Earnings: EPS estimate is (0.67) USD

Bionano Genomics, Inc. (BNGO) is scheduled to release its Q2'26 financial results on August 10, after market close. The company is expected to report an estimated revenue of $7.55 million and an estimated earnings per share (EPS) of ($0.67) for the quarter. This article …

AngioDynamics SmartPort Infection Lawsuit Alleges Defective Port Caused Sepsis

A Pennsylvania man has filed a lawsuit against AngioDynamics and Navilyst Medical, alleging that a defective SmartPort catheter caused a severe infection and sepsis, necessitating its surgical removal. The complaint claims that defects in the port catheter promoted bacterial growth and that the companies …

Embecta Corp. (Nasdaq: EMBC) Q3 2026 revenue dips as earnings outlook raised

Sarasin & Partners LLP Grows Holdings in Intuitive Surgical, Inc. $ISRG

Sarasin & Partners LLP significantly increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 128.2% in the second quarter, now owning 244,426 shares valued at $97.2 million. This comes as Intuitive Surgical reported stronger-than-expected quarterly results, with EPS of $2.80 and revenue of $2.89 …